指南与共识系统性红斑狼疮其他结缔组织病

CARRA/PReS 认可的儿童期起病系统性红斑狼疮核心与扩展数据集制定:用于国际注册登记研究

Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
指南 / 共识 · Ann Rheum Dis · 2025-01-02

由 CARRA 与 PReS 支持,21 名国际 cSLE 专家和 4 名患者通过德尔菲法(问卷、2 个专题焦点小组和 3 次虚拟共识会议)制定核心与扩展 cSLE 数据集,共识定义为同意率>80%。核心数据集含 46 项,扩展数据集增加 26 项并纳入患者报告结局,同时确定基线、每季度随访、每年和发作就诊的数据收集频率与时间点。

要点

  • 核心 cSLE 数据集含 46 项,涵盖人口学、临床特征、实验室结果、药物和显著不良事件。
  • 扩展 cSLE 数据集在核心基础上增加 26 项,并纳入患者报告结局。
  • 共识确定数据收集时间点为基线、每季度随访、每年和发作就诊。

核心结论

  • 通过全球专家及患者/照护者代表共识,定义了用于注册登记国际 cSLE 研究的标准化核心与扩展 cSLE 数据集,并获得 CARRA 和 PReS 认可。
  • 这些数据集纳入疾病特异性和患者特异性特征,针对不同环境优化,以促进全球儿童和青少年 SLE 的国际合作研究。

研究设计与样本

  • 21 名国际 cSLE 专家和 4 名患者参与德尔菲过程(问卷、2 个专题焦点小组和 3 次虚拟共识会议)制定 2 个标准化 cSLE 数据集。
  • 最终数据项通过改良名义群体技术和投票确定,共识定义为同意率>80%。

主要发现

  • 核心 cSLE 数据集包含 46 项,包括人口学、临床特征、实验室结果、药物和显著不良事件。
  • 扩展 cSLE 数据集增加 26 项额外数据项,并纳入患者报告结局。
  • 就数据收集频率和时间点达成共识:基线、每季度随访、每年和发作就诊。

关键数值与推荐

  • 共识定义为同意率>80%。
  • 核心 cSLE 数据集含 46 项。
  • 扩展 cSLE 数据集在核心数据集基础上增加 26 项。
  • 数据收集时间点为基线、每季度随访、每年和发作就诊。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Childhood-onset systemic lupus erythematosus (cSLE), representing 15%-20% of individuals with SLE, has been difficult to study globally due to differences between registries. This initiative, supported by Childhood Arthritis Rheumatology Research Alliance (CARRA) and Paediatric Rheumatology European Society (PReS), aims to create Core and Expanded cSLE Datasets to standardise and enhance research worldwide. METHODS: 21 international cSLE experts and 4 patients participated in a Delphi process (questionnaires, 2 topic-specific focus groups and 3 virtual consensus meetings) to create 2 standardised cSLE datasets. The Core cSLE Dataset was designed to include data essential to meaningful clinical research across many settings. The Expanded cSLE Dataset was designed for centres able to consistently collect data to address broader research questions. Final data items for the Core and Expanded datasets were determined by consensus defined as >80% agreement) using an adapted nominal group technique and voting. RESULTS: The resulting Core cSLE Dataset contains 46 items, including demographics, clinical features, laboratory results, medications and significant adverse events. The Expanded cSLE Dataset adds 26 additional items and includes patient-reported outcomes. Consensus was also achieved regarding the frequency and time points for data collection: baseline, quarterly follow-up visits, annually and flare visits. CONCLUSION: Standardised Core and Expanded cSLE Datasets for registry-based international cSLE research were defined through the consensus of global experts and patient/caregiver representatives, endorsed by CARRA and PReS. These datasets incorporate disease-specific and patient-specific features, optimised for diverse settings to facilitate international collaborative research for children and adolescents with SLE worldwide.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Sadun RE, Cooper JC, Belot A, et al. Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Ann Rheum Dis. 2025. PMID: 39919891. doi:10.1136/ard-2024-226528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。